N/A
N=216
Treatment Advocacy Intervention for HIV-Positive African Americans
HIV
Bottom Line
View on ClinicalTrials.gov: NCT01350544 ↗Enrolled (actual)
216
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcome: Primary: Medication Adherence — 77.96; 80.13; 64.87; 76.13 Percentage of doses taken — p=.005
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Treatment Advocacy (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston Children's Hospital
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Adherence |
77.96; 80.13; 64.87; 76.13; 63.44; 76.76 | .005 sig |
Summary
The investigators hypothesize that participants in the treatment advocacy intervention will show significantly better HIV treatment adherence than will participants in the no-treatment (wait-list) control group.
Eligibility Criteria
Inclusion Criteria
- 18 years of age or older;
- self-identify as African American or Black
- client of APLA
- they are on ART and missed at least 1 dose in the past month
- they have a currently detectable or unknown HIV viral load (or have not had a viral load test within the last six months).
Exclusion Criteria
- received treatment advocacy in last 6 months
Data sourced from ClinicalTrials.gov (NCT01350544). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.